Discontinuation of Prophylaxis against<i>Mycobacterium avium</i>Complex Disease in HIV-Infected Patients Who Have a Response to Antiretroviral TherapyWafaa El‐Sadr, Fred M. Gordin, William J. Burman et al.|New England Journal of Medicine|2000Cited by 156
Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy VolunteersKelly E. Dooley, Yoninah Cramer, Richard Hafner et al.|Antimicrobial Agents and Chemotherapy|2015Cited by 21